The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease-Reference-Cited by-同舟云学术

The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease

Published:2013-03-20 Issue:4 Volume:34 Page:985-994
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Wang-Dietrich Lei¹,Funke Susanne Aileen¹,Kühbach Katja¹,Wang Kun¹,Besmehn Astrid²,Willbold Sabine²,Cinar Yeliz¹,Bannach Oliver³,Birkmann Eva¹³,Willbold Dieter¹³

Affiliation:

1. Institute of Complex Systems, ICS-6: Structural Biochemistry, Forschungszentrum Jülich, Jülich, Germany

2. ZCH, Forschungszentrum Jülich, Jülich, Germany

3. Institut für Physikalische Biologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent organic framework-based ratiometric electrochemical sensing platform for ultrasensitive determination of amyloid-β 42 oligomer;Talanta;2024-12

2. Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-04

3. Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease;Heliyon;2023-08

4. Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer’s Disease;Diagnostics;2023-05-11

5. Oligomeropathies, inflammation and prion protein binding;Frontiers in Neuroscience;2022-08-23